Epstein-Barr Virus associated Leiomyosarcoma (EBV LMS)
Showing 1 - 25 of >10,000
Epstein-Barr Virus (EBV) Infections, Lymphoproliferative Disorders, EBV+ Associated Lymphoma Trial (tabelecleucel)
Available
- Epstein-Barr Virus (EBV) Infections
- +11 more
- tabelecleucel
- (no location specified)
Feb 15, 2022
Epstein-Barr Virus (EBV)-Associated Diseases, EBV+ Lymphoproliferative Disease With Primary Immunodeficiency (PID LPD), EBV+
Recruiting
- Epstein-Barr Virus (EBV)-Associated Diseases
- +13 more
- Tabelecleucel
-
Los Angeles, California
- +39 more
Nov 9, 2022
Immune Function and PD-1 Antibody Therapy Efficacy Predictors on
Recruiting
- Secondary Hemophagocytic Lymphohistiocytosis
- Chronic Active Epstein-Barr Virus Infection
- No intervention
-
Beijing, Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
May 2, 2023
PD-1 Antibody, Hemophagocytic Lymphohistiocytosis, Epstein-Barr Virus Trial in Beijing (L-DEP and PD-1 antibody)
Not yet recruiting
- PD-1 Antibody
- +3 more
- L-DEP and PD-1 antibody
-
Beijing, Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
Mar 8, 2023
Epstein-Barr Virus Infection moniToring in renAl Transplant
Recruiting
- EBV Infection
- +3 more
- EBV DNA in whole blood and plasma
-
Aarhus, Central Region Denmark, Denmark
- +2 more
Dec 12, 2022
Secondary Hemophagocytic Lymphohistiocytosis, Chronic Active Epstein-Barr Virus Infection Trial in Beijing (Rituximab
Recruiting
- Secondary Hemophagocytic Lymphohistiocytosis
- Chronic Active Epstein-Barr Virus Infection
- Rituximab Monotherapy
-
Beijing, ChinaZhao Wang
May 18, 2022
Epstein Barr Virus Infection in Radiologically Isolated Syndrome
Recruiting
- Multiple Sclerosis
- +2 more
- NO INTERVENTION
-
Nice, FranceNice University Hospital
Apr 3, 2023
Epstein-Barr Virus Infections, Lymphoma, Lymphoproliferative Disorder Trial run by the NCI (Nivolumab)
Recruiting
- Epstein-Barr Virus Infections
- +3 more
- Nivolumab
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 24, 2023
Early Detection of Epstein-Barr Virus Related Disease.
Active, not recruiting
- Post-transplant Lymphoproliferative Disorder
- +8 more
-
Aarhus, Central Region Of Denmark, DenmarkAarhus University Hospital
Dec 12, 2022
Epstein-Barr Virus Infection, Infectious Mononucleosis, Herpesvirus Trial run by the National Institute of Allergy and
Not yet recruiting
- Epstein-Barr Virus Infection
- +2 more
- Matrix-M1 Adjuvant
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
EBV-associated Hemophagocytic Lymphohistiocytosis, EBV Infection Trial in Beijing (EBV-TCR-T cells)
Recruiting
- EBV-associated Hemophagocytic Lymphohistiocytosis
- EBV Infection
- EBV-TCR-T cells
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Nov 12, 2023
Segmental Resection Combined With DEP Regimen for EBV-HLH
Not yet recruiting
- Hemophagocytic Lymphohistiocytosis
- +2 more
- Segmental bowel resection combined with the DEP regimen
-
Beijing, Beijing, ChinaZhao Wang
Nov 9, 2023
CMV Infection, EBV Infection, Stem Cell Transplant Trial (Virus specific T cells)
Not yet recruiting
- CMV Infection
- +2 more
- Virus specific T cells
- (no location specified)
Oct 4, 2023
Epstein-Barr Virus Antibody and Epstein-Barr Virus DNA for
Recruiting
- Nasopharyngeal Carcinoma
- EBV antibodies test
- EBV DNA test
-
Guangzhou, Guangdong, ChinaDepartment of Nasopharyngeal Carcinoma, Sun Yat-sen University C
Jul 6, 2022
Nasopharyngeal Cancer, Epstein-Barr Virus Related Carcinoma Trial in Stanford (VK-2019)
Recruiting
- Nasopharyngeal Cancer
- Epstein-Barr Virus Related Carcinoma
-
Stanford, CaliforniaStanford University
Mar 31, 2022
Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, Epstein-Barr Virus-Associated Gastric Carcinoma Trial
Not yet recruiting
- Adenocarcinoma of the Stomach
- +2 more
- Toripalimab
- +2 more
-
Hangzhou, Zhejiang, China
- +7 more
Jul 25, 2023
EBV, Epstein-Barr Virus Infection, Infectious Mononucleosis Trial run by the NIAID (EBV gp350-Ferritin Vaccine, Matrix-M1)
Recruiting
- EBV
- +2 more
- EBV gp350-Ferritin Vaccine
- Matrix-M1
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 11, 2022
EBV-positive Gastric Cancer and Multiple Genes Associated With
Completed
- Gastric Cancer
- +2 more
- Gastrectomy
-
Suwon, Gyeong-Gi-Do, Korea, Republic ofJiwon Seo
Oct 28, 2022
Epstein-Barr Virus Infections, Primary Immune Deficiency Disorder Trial in United States (cytotoxic t-lymphocytes)
Recruiting
- Epstein-Barr Virus Infections
- Primary Immune Deficiency Disorder
- cytotoxic t-lymphocytes
-
Los Angeles, California
- +7 more
Sep 27, 2022
Acute Lymphocytic Leukemia, Lymphoma Trial in New York (Biological/Genetically Modified T cells, Cyclophosphamide-based chemo)
Active, not recruiting
- Acute Lymphocytic Leukemia
- Lymphoma
- Biological/Genetically Modified T cells
- Cyclophosphamide-based chemotherapy
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 3, 2023
EBV Infection After Allogenic HSCT Trial in Beijing (EBV-TCR-T cells)
Recruiting
- EBV Infection After Allogenic HSCT
- EBV-TCR-T cells
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Nov 3, 2023
Study on Infectious Mononucleosis in Munich
Completed
- Infectious Mononucleosis
- Epstein-Barr Virus Infections
-
Munich, Bavaria, GermanyMRI Chonic Fatigue Center for Young People (MCFC), Children's Ho
Aug 16, 2023
EBV Associated Extranodal NK/T-cell Lymphoma, EBV-Associated GastricCarcinoma or Esophageal AdenoCarcinoma Trial in Korea,
Recruiting
- EBV Associated Extranodal NK/T-cell Lymphoma
- EBV-Associated GastricCarcinoma or Esophageal AdenoCarcinoma
- EBViNT Cell
-
Seoul, Gangnam-gu, Korea, Republic of
- +7 more
Jul 7, 2022
Verification of Harmonization of Plasma Epstein-Barr Virus DNA
Recruiting
- Nasopharyngeal Carcinoma
- Plasma EBV DNA qPCR test
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Jul 3, 2022
EBV Infection Trial in Belgium (2LEBV® / 2LXFS®, Placebo)
Recruiting
- EBV Infection
- 2LEBV® / 2LXFS®
- Placebo
-
Aartselaar, Belgium
- +12 more
Dec 22, 2022